Skip to main content
. 2017 Aug 1;8(45):79809–79815. doi: 10.18632/oncotarget.19748

Figure 2. Kaplan-Meier progression free survival (PFS) curves according to baseline REC.

Figure 2

REC < 1.5%: dotted lines; REC ≥ 1.5%: solid lines. Black lines: chemotherapy-treated patients (cohort A); grey lines: anti-CTLA-4-treated patients (cohort B).